The Patent Finder

Terms ending in 2029

Array Biopharma Inc.

Every in-force patent on Array Biopharma Inc.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 8,329,7095H-CYCLOPENTA[D]PYRIMIDINES as Akt Protein Kinase Inhibitors
In force
 · High confidence
Array Biopharma Inc.In forceHigh confidence
US 9,328,0915H-CYCLOPENTA[d]PYRIMIDINES AS AKT PROTEIN KINASE INHIBITORS
In force
 · High confidence
Array Biopharma, Inc.In forceHigh confidence
US 8,202,899Pyrazole Urea Derivatives Used as Kinase Inhibitors
In force
 · High confidence
Array Biopharma, Inc.In forceHigh confidence
US 11,813,246Pharmaceutical Composition
In force
 · Medium confidence
Alexion Pharma International Operations LimitedIn forceMedium confidence
US 12,220,403Pharmaceutical Composition
In force
 · Low confidence
Alexion Pharma International Operations LimitedIn forceLow confidence
US 12,318,367Pharmaceutical Composition
In force
 · Low confidence
Alexion Pharma International Operations LimitedIn forceLow confidence
US 12,364,684Pharmaceutical Composition
In force
 · Low confidence
Alexion Pharma International Operations LimitedIn forceLow confidence
US 8,895,5665H-CYCLOPENTA[D]PYRIMIDINES as Akt Protein Kinase Inhibitors
In force
 · High confidence
Genentech, Inc.In forceHigh confidence
US 7,425,637N3 Alkylated Benzimidazole Derivatives as Mek Inhibitors
In force
 · High confidence
Alexion Pharma International Operations LimitedIn forceHigh confidence
US 8,178,131Pyrrolopyridines as Kinase Inhibitors
In force
 · High confidence
Array Biopharma, Inc.In forceHigh confidence
19 more term ends in 2029 · Pro
10 of 29 patents shown. Soonest term end first, then patent number.
Pro members see all 29.
Upgrade to Pro
21 of these are in force and held by Array Biopharma Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited